Dec. 19, 2024 — Scientists have unveiled groundbreaking research on the origins of lunar water, offering insights that could reshape our understanding of the Earth-Moon system and the broader ...

Percheron Therapeutics' board of directors has written a letter to shareholders following failure of its phase 2b trial.

Oh, tourists. At Rome's Trevi Fountain, inappropriate tourist behavior is forcing the government to change some rules. Here's what to know.

The individual behavior of a patient’s myeloproliferative neoplasm (MPN) will determine how the disease is monitored and managed in the long term, explained Jennifer Vaughn, MD, of The Ohio ...

MARKETING-INTERACTIVE is an online publication of Lighthouse Independent Media.

Tim Mok, PharmD, BCPS, BCOP, malignant hematology pharmacy research analyst at Kaiser Permanente, discussed his perspective on the balance between clinical outcomes and cost considerations.

Equipped with next-generation Primary RGB Tandem Panel and Panasonic's revolutionary ThermalFlow aerodynamic cooling system ...

Kamilia Smith, MD, FACOG, NCMP, discusses how shared decision-making approaches combined with emerging neurokinin-targeted therapies offer promising solutions to improve treatment adherence and ...

The updated guidelines from the American Diabetes Association emphasize the use of antibody-based screening for type 1 diabetes and recommend that physicians discuss potential use of Tzield, a ...

Anthony Albanese calls for bold change to Australia's elections and hints the federal election date for 2025.

Jan. 6, 2025 — People who care for both their children and older family members -- also known as 'sandwich carers' -- suffer from deterioration in both their mental and physical health over time ...

Hard on the heels of some impressive clinical trial results, Luminopia has won FDA approval for its digital therapeutic (DTx) for amblyopia or lazy eye in children that is based on watching TV shows.